1. Hepatocyte growth factor/MET in cancer progression and biomarker discovery
    Kunio Matsumoto et al, 2017, Cancer Sci CrossRef
  2. Overexpression of ING5 inhibits HGF-induced proliferation, invasion and EMT in thyroid cancer cells via regulation of the c-Met/PI3K/Akt signaling pathway
    Wei Gao et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  3. Inhibitory effects of tetrandrine on epidermal growth factor-induced invasion and migration in HT29 human colorectal adenocarcinoma cells
    CHI-TING HORNG et al, 2016 CrossRef
  4. Plasma T790M and HGF as potential predictive markers for EGFR-TKI re-challenge
    Tomomi Nakamura et al, 2017 CrossRef
  5. null
    Dinuka M. De Silva et al, 2018 CrossRef
  6. Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways in lung cancer
    Demin Jiao et al, 2016, Molecular Therapy - Oncolytics CrossRef
  7. HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers.
    Fatemeh Moosavi et al, 2019, Crit Rev Clin Lab Sci CrossRef
  8. Extensive serum biomarker analysis in patients with non-small-cell lung carcinoma.
    Donghao Cai et al, 2020, Cytokine CrossRef
  9. Clinical impact of high serum hepatocyte growth factor in advanced non-small cell lung cancer
    Takahiro Tsuji et al, 2017, Oncotarget CrossRef
  10. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway
    Qing-yong Chen et al, 2016, Oncotarget CrossRef
  11. MiR-144-3p inhibits the proliferation and metastasis of lung cancer A549 cells via targeting HGF
    Guiju Fang et al, 2022, J Cardiothorac Surg CrossRef
  12. Abnormal activation of NF‐κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid‐derived suppressor cells to shape the immunosuppressive tumor immune microenvironment
    Chao Wang et al, 2023, Thoracic Cancer CrossRef
  13. Plasma hepatocyte growth factor as a noninvasive biomarker in small cell lung cancer
    Cong Zhao et al, 2023, BMC Cancer CrossRef
  14. Hexane Fraction of Adenophora triphylla var. japonica Root Extract Inhibits Angiogenesis and Endothelial Cell-Induced Erlotinib Resistance in Lung Cancer Cells
    Hyun-Ji Park et al, 2024, Molecules CrossRef
  15. Natural Products for Combating Multidrug Resistance in Cancer
    Ting Chen et al, 2024, Pharmacological Research CrossRef
  16. TWIST1 is a critical downstream target of the HGF/MET pathway and is required for MET driven acquired resistance in oncogene driven lung cancer
    Vinod Kumar et al, 2024, Oncogene CrossRef